Interestingly in a study in breast cancer patient43, autoantibodies to RPA2 were detected before diagnosis of invasive tumours and anti-RPA2 antibodies were also prevalent in DCIS indicating a role for RPA during breast cancer pathogenesis43. This evidence concerns the gene RPA2 and ductal breast carcinoma in situ.